Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted Therapy of HER2-Negative Breast Cancer.
Schütz F, Domschke C, Schneeweiss A. Schütz F, et al. Among authors: domschke c. Oncol Res Treat. 2016;39(3):118-21. doi: 10.1159/000444204. Epub 2016 Feb 10. Oncol Res Treat. 2016. PMID: 27031995 Review.
Long-term objective esthetic outcome after breast-conserving therapy.
Hennigs A, Hartmann B, Rauch G, Golatta M, Tabatabai P, Domschke C, Schott S, Schütz F, Sohn C, Heil J. Hennigs A, et al. Among authors: domschke c. Breast Cancer Res Treat. 2015 Sep;153(2):345-51. doi: 10.1007/s10549-015-3540-y. Epub 2015 Aug 13. Breast Cancer Res Treat. 2015. PMID: 26267662
Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer.
Deutsch TM, Riethdorf S, Nees J, Hartkopf AD, Schönfisch B, Domschke C, Sprick MR, Schütz F, Brucker SY, Stefanovic S, Sohn C, Pantel K, Trumpp A, Schneeweiss A, Wallwiener M. Deutsch TM, et al. Among authors: domschke c. Breast Cancer Res Treat. 2016 Nov;160(2):277-290. doi: 10.1007/s10549-016-3997-3. Epub 2016 Oct 1. Breast Cancer Res Treat. 2016. PMID: 27696083
PD-1/PD-L1 Pathway in Breast Cancer.
Schütz F, Stefanovic S, Mayer L, von Au A, Domschke C, Sohn C. Schütz F, et al. Among authors: domschke c. Oncol Res Treat. 2017;40(5):294-297. doi: 10.1159/000464353. Epub 2017 Mar 27. Oncol Res Treat. 2017. PMID: 28346916 Free article. Review.
Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosis.
Domschke C, Schuetz F, Ge Y, Seibel T, Falk C, Brors B, Vlodavsky I, Sommerfeldt N, Sinn HP, Kühnle MC, Schneeweiss A, Scharf A, Sohn C, Schirrmacher V, Moldenhauer G, Momburg F, Beckhove P. Domschke C, et al. Cancer Res. 2009 Nov 1;69(21):8420-8. doi: 10.1158/0008-5472.CAN-09-1627. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843863
Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome.
Ge Y, Domschke C, Stoiber N, Schott S, Heil J, Rom J, Blumenstein M, Thum J, Sohn C, Schneeweiss A, Beckhove P, Schuetz F. Ge Y, et al. Among authors: domschke c. Cancer Immunol Immunother. 2012 Mar;61(3):353-62. doi: 10.1007/s00262-011-1106-3. Epub 2011 Sep 14. Cancer Immunol Immunother. 2012. PMID: 21915801 Free PMC article. Clinical Trial.
Predictors of resectability in breast-conserving therapy.
Rath MG, Heil J, Domschke C, Topic Z, Schneider S, Sinn HP, Marme F, Scharf A, Schneeweiss A, Sohn C, Rom J. Rath MG, et al. Among authors: domschke c. Arch Gynecol Obstet. 2012 Oct;286(4):1023-31. doi: 10.1007/s00404-012-2401-8. Epub 2012 Jun 17. Arch Gynecol Obstet. 2012. PMID: 22707290
68 results